HOPE MCLENDON: Open Payments
NPI 1417308040 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 37 payments from 25 companies in 2025. Trend: 2023 $1,172 · 2024 $2,268 · 2025 $993
Food & beverage: $767Long term medical supply or device loan: $183Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $228 |
| BeOne Medicines USA, Inc. | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $62 |
| Janssen Biotech, Inc. | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $44 |
| Celgene Corporation | 2 | $42 |
| PFIZER INC. | 2 | $39 |
| Adaptive Biotechnologies Corporation | 2 | $36 |
| Legend Biotech USA Inc. | 1 | $33 |
Products named: KISQALI, BRUKINSA, OJJAARA, Trodelvy, ENHERTU, OPDIVO, clonoSEQ, CARVYKTI.
Industry payments across SC — which companies pay providers there.
